Product Benefits

• Combines a high‑potency corticosteroid (Clobetasol Propionate 0.05%) with a keratolytic agent (Salicylic Acid 3%) to treat thickened, scaly, stubborn skin lesions.

• Effective in skin conditions like psoriasis (excluding widespread plaque psoriasis), lichen planus, ichthyosis, chronic relapsing dermatoses and hand/foot eczema where milder treatments failed.

• Helps soften and remove dead skin layers via Salicylic Acid, improving the penetration and action of Clobetasol.

• Topical application allows direct treatment of affected areas with reduced systemic exposure compared to oral therapies.

• Available locally in Bangladesh, improving accessibility for dermatological care.